Clinical Proteomics

News on proteomics applications for clinical use in genetics, genomics, and molecular diagnostics.

With Medicare coverage for the test in place, the company is hoping it will surpass the limited commercial success of its initial Xpresys Lung offering.

Progenetics will distribute GeneStrat and Veristrat liquid biopsy tests in Israel, making Biodesix's tests available in the Middle East for the first time.

The new platform adds multiplexing capability to TearLab's current platform, which will help the firm develop clinical assays for eye and other diseases.

The company plans to use the proceeds to support research collaborations and to expand its commercial team.

The assay is designed to measure changes in blood levels of the peptide precursor procalcitonin to differentiate bacterial infections from viral ones.